Cardiol Therapeutics's total assets for Q1 2025 were C$25.45M, a decrease of -20.11% from the previous quarter. CRDL total liabilities were C$7.87M for the fiscal quarter, a 10.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.